VERGANI BARBARA
- U08, Piano: 1I, Stanza: LABORATORIO M.I.A.
Pubblicazioni
Pisani, I., Melita, G., de Souza, P., Galimberti, S., Savino, A., Sarno, J., et al. (2025). Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability. JOURNAL OF TRANSLATIONAL MEDICINE, 23(1) [10.1186/s12967-025-06416-3]. Dettaglio
Monti, M., Benerini Gatta, L., Bugatti, M., Pezzali, I., Picinoli, S., Manfredi, M., et al. (2024). Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness. JOURNAL OF TRANSLATIONAL MEDICINE, 22(1) [10.1186/s12967-023-04784-2]. Dettaglio
Franchin, M., Vergani, B., Huber, V., Leone, B., Villa, A., Muscato, P., et al. (2024). Proposal of a classification of cannulation damage in vascular access grafts based on clinical, ultrasound, and microscopic observations. JOURNAL OF VASCULAR ACCESS [10.1177/11297298241248263]. Dettaglio
Cellupica, E., Gaiassi, A., Rocchio, I., Rovelli, G., Pomarico, R., Sandrone, G., et al. (2024). Mechanistic and Structural Insights on Difluoromethyl-1,3,4-Oxadiazole Inhibitors of HDAC6. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 25(11), 1-12 [10.3390/ijms25115885]. Dettaglio
Rivoltini, L., Camisaschi, C., Fucà, G., Paolini, B., Vergani, B., Beretta, V., et al. (2024). Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade. SCIENTIFIC REPORTS, 14(1) [10.1038/s41598-024-54041-9]. Dettaglio